Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
30/100
Pipeline Velocity
0/100
Trial Completion Rate
88/100
Pipeline Concentration
100/100
Pipeline Freshness
61/100
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Potassium Iodide — POTASSIUM IODIDE
Application NDA018551 (NDA)
Potassium Iodide — THYRO-BLOCK
Application NDA018307 (NDA)
Potassium Iodide — IOSAT
Application NDA018664 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)